21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
13.92.Z - Production of textile products for households and ready-made interior items
20.41.Z - Manufacture of soap and detergents, cleaning and polishing preparations
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
22.29.Z - Manufacture of rubber and plastic products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
72.19.Z - Scientific research and development activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -0 | 11,4 | 1 123 840,3 |
EBITDA | -0 | 13,6 | 1 338 707,7 |
Short time liabilities | 0 | 97,7 | -∞ |
Equity capital | 0 | 413,9 | 10 392 022,1 |
Operating profit (EBIT) | -0 | 10,5 | 1 029 107 |
Assets | 0 | 518,7 | 13 024 587,8 |
Net profit (loss) | -0 | 8,3 | 818 258,2 |
Cash | 0 | 0,6 | 15 798 |
Liabilities and provisions for liabilities | 0 | 104,8 | -∞ |
Net income from sale | 0 | 71,2 | -∞ |
Working assets | 0 | 239 | 6 000 289,3 |
Depreciation | 0 | 3,2 | -∞ |
% | % | p.p. | |
Profitability of capital | -25,6 | 2 | 27,6 |
Equity capital to total assets | 100 | 79,8 | -20,2 |
Gross profit margin | 16,1 | ||
EBITDA Margin | 19,1 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 501 | 501 |
Current financial liquidity indicator | 2.423363447189331 | ||
Net dept to EBITDA | 3.8634040355682373 | 0.0038815168663859367 | -3,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane